Incorporated in 1976 and based in Waltham, MA, Nova Biomedical is a world leader in the development and manufacturing of state-of-the-art whole blood chemistry analyzers and is one of the fastest growing in vitro diagnostic companies in the world. Nova’s whole blood biosensor technology is incorporated in products ranging from handheld meters for glucose self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes. Nova sales and service operations are worldwide with local subsidiaries or distributors in 100 countries, and wholly owned subsidiaries located in Canada, France, Germany, Great Britain, and Japan. Certified by the International Organization for Standardization, Nova’s state-of-the-art manufacturing operations are and located in the U.S. and abroad.